Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of Dacomitinib and Osimertinib for Patients With Advanced EGFR Mutant Lung Cancer

Memorial Sloan Kettering Cancer Center · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
metastatic non-small cell lung cancer, dacomitinib, osimertinib, egfr mutant lung cancers, 18-411, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 804111
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.